Compare CP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CP | BSX |
|---|---|---|
| Founded | 1881 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.0B | 65.8B |
| IPO Year | 2000 | 2010 |
| Metric | CP | BSX |
|---|---|---|
| Price | $90.03 | $48.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 22 |
| Target Price | ★ $93.67 | $93.18 |
| AVG Volume (30 Days) | 2.7M | ★ 17.5M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | 13.32 | ★ 55.20 |
| EPS | ★ 2.10 | 1.51 |
| Revenue | ★ $15,078,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $8.71 | $11.85 |
| Revenue Next Year | $6.15 | $10.16 |
| P/E Ratio | $43.55 | ★ $31.62 |
| Revenue Growth | 3.66 | ★ 12.49 |
| 52 Week Low | $68.42 | $42.20 |
| 52 Week High | $93.95 | $109.50 |
| Indicator | CP | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 64.23 |
| Support Level | $83.55 | $47.17 |
| Resistance Level | $91.51 | $50.14 |
| Average True Range (ATR) | 1.91 | 1.54 |
| MACD | -0.17 | 0.68 |
| Stochastic Oscillator | 59.79 | 96.00 |
Canadian Pacific Kansas City is a Class I railroad operating on tracks that span most of Canada and into parts of the Midwestern and Northeastern United States. Following the April 2023 Kansas City Southern merger, CPKC operates new single-linehaul services from Canada and the Upper Midwest down through Texas, the Gulf of Mexico, and into Mexico. It also hauls cross-border and intra-Mexico freight via operating concessions on more than 3,000 miles of rail in Mexico. CPKC hauls shipments of grain, intermodal containers, energy products (like crude and frac sand), chemicals, plastics, coal, fertilizer and potash, automotive products, and a diverse mix of other merchandise.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.